Unicycive Therapeutics Balance Sheet (2020-2026)

Reported Financials

Unicycive Therapeutics Quarterly Balance Sheet

Periods 25 quarters

Latest Jun 2026

Unicycive Therapeutics reported total assets of $72.03M and total liabilities of $18.76M for the quarter ended Jun 2026, up 140.1% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	18.01M	16.58M	13.62M	10.57M	7.01M	0.46M	24.33M	18.82M	14.35M	9.70M	48.93M	41.78M	32.35M	26.14M	19.77M	22.33M	42.70M	29.20M	37.37M	44.19M
Short-term InvestmentsInvestments (Current)																		12.07M	17.22M	17.24M
Cash & Current Investments	18.01M	16.58M	13.62M	10.57M	7.01M	0.46M	24.33M	18.82M	14.35M	9.70M	48.93M	41.78M	32.35M	26.14M	19.77M	22.33M	42.70M	41.27M	54.59M	61.43M
Receivables - OtherOther Receivables	0.10M
Inventory														3.60M				6.19M	7.69M	7.60M
Prepaid Assets	1.71M	1.83M	1.84M	1.99M	2.95M	2.19M	1.85M	3.11M	4.22M	3.70M	2.75M	2.27M	5.39M	4.81M	7.58M	7.20M	7.59M	7.69M	8.96M	9.90M
Current Assets	19.78M	18.41M	15.46M	12.56M	9.96M	2.64M	26.18M	21.93M	18.57M	13.40M	51.68M	44.05M	37.74M	30.95M	27.35M	29.53M	50.29M	48.96M	63.55M	71.32M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)		0.03M	0.03M	0.03M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.02M	0.04M	0.06M	0.08M	0.08M	0.08M	0.08M	0.07M	0.05M	0.04M
Other Non-Current Assets
Non-Current Assets		0.33M	0.30M	0.26M	0.22M	0.17M	1.02M	0.95M	0.87M	0.79M	0.71M	0.65M	0.83M	0.72M	0.60M	0.47M	0.32M	0.17M	0.86M	0.71M
Assets	19.78M	18.74M	15.76M	12.82M	10.18M	2.82M	27.20M	22.88M	19.44M	14.19M	52.39M	44.70M	38.57M	31.67M	27.95M	30.00M	50.61M	49.14M	64.41M	72.03M
Liabilities
Current Liabilities
Accounts Payables	0.05M	0.74M	0.59M	0.75M	2.29M	0.89M	0.79M	0.50M	1.08M	2.00M	1.24M	1.47M	0.55M	1.06M	1.40M	0.78M	0.96M	0.38M	1.14M	2.23M
Notes Payables
Dividends payables												0.00M
Payables	0.05M	0.74M	0.59M	0.75M	2.29M	0.89M	0.79M	0.50M	1.08M	2.00M	1.24M	1.47M	0.55M	1.06M	1.40M	0.78M	0.96M	0.38M	1.14M	2.23M
Accumulated Expenses	0.63M	1.21M	1.66M	1.93M	3.07M	2.24M	1.70M	1.69M	2.53M	3.23M	3.55M	3.12M	2.99M	3.56M	4.14M	2.17M	2.76M	1.52M	3.05M	2.14M
Other Accumulated Expenses		0.15M	0.15M			0.52M			0.50M	0.28M	0.25M	0.12M	0.52M	0.39M	0.81M	0.41M	0.41M	0.44M	1.65M	0.52M
Short term Debt	0.10M										0.21M
Total Current Liabilities	0.79M	2.11M	2.40M	2.83M	5.52M	3.28M	15.97M	15.42M	15.46M	17.53M	30.28M	13.09M	10.46M	24.12M	16.68M	13.57M	13.13M	18.94M	26.49M	18.70M
Non-Current Liabilities
Preferred Stock Liabilities							25.60M	26.20M			46.19M	46.19M
Operating Leases		0.16M	0.11M	0.07M	0.03M		0.72M	0.63M	0.55M	0.47M	0.37M	0.27M	0.27M	0.12M					0.22M	0.06M
Other Non-Current Liabilities						10.38M	13.21M	12.92M	11.53M	13.13M	24.94M	8.13M	6.38M	18.94M	10.59M	10.21M	9.15M	16.92M	21.70M	13.72M
Total Non-Current Liabilities						-7.09M	29.08M	29.33M	4.48M	4.87M	51.90M	51.42M	60.05M	5.30M	6.09M	3.35M	3.98M	2.02M	5.01M	5.04M
Total Liabilities	0.79M	2.26M	2.52M	2.91M	5.55M	3.28M	42.28M	42.26M	16.01M	18.00M	76.84M	59.55M	66.42M	24.24M	16.68M	13.57M	13.13M	18.94M	26.70M	18.76M
Shareholder's Equity
Total Debt	0.10M										0.21M
Common Equity	19.00M	16.48M	13.24M	9.91M	4.63M	-0.47M	-15.08M	-19.37M	3.43M	-3.81M	-24.46M	-14.85M	-27.85M	7.43M	11.27M	16.43M	37.48M	30.20M	37.70M	53.27M
Liabilities and Shareholders Equity	19.78M	18.74M	15.76M	12.82M	10.18M	2.82M	27.20M	22.88M	19.44M	14.19M	52.39M	44.70M	38.57M	31.67M	27.95M	30.00M	50.61M	49.14M	64.41M	72.03M
Retained Earnings	-13.19M	-15.94M	-19.48M	-23.11M	-28.67M	-34.00M	-48.57M	-52.41M	-56.74M	-64.54M	-85.50M	-75.65M	-79.75M	-101.30M	-127.80M	-107.15M	-113.20M	-127.83M	-140.65M	-142.40M
Preferred Shares									0.04M
Treasury Shares		0.67M				0.39M	0.35M	11.87M	2.80M	2.82M	2.80M	8.03M	7.43M	7.43M

Unicycive Therapeutics Balance Sheet API

Pull Unicycive Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UNCY&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "UNCY", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=UNCY&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Unicycive Therapeutics UNCY Balance Sheet (2020-2026)

Unicycive Therapeutics Quarterly Balance Sheet

Unicycive Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password